Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Global Liposome Drug Delivery Market Size study, by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others), by Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology), by Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Regional Forecasts 2022-2028
... Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Regional Forecasts 2022-2028Global Liposome Drug Delivery Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Global Missouri Medical Cannabis Market Size study, By Product Type (Flower, Oils & Tinctures), By Application (Cancer, Chronic Pain, Arthritis, Diabetes, AIDS, Others), and Regional Forecasts 2022-2028
... USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Missouri medical cannabis is also known as marijuana, which is any strain ... Read More
-
Uveitis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
... reach US$ 2.2 Billion by 2027, exhibiting a CAGR of 5.95% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of ... Read More
-
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) - Global Forecast to 2027
... equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, ... Read More
-
Global Pleurodynia Treatment Market 2022-2026
... Our report on the pleurodynia treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) - Global Forecast to 2027
... market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence ... Read More
-
Small Molecule Injectable Drugs Market, by Drug Class (Chemotherapy, Small Molecule Antibiotics, Skeletal Muscle Relaxants, Analgesics, Anticoagulants, Anticonvulsants, Antivirals, and Others), by Indication (Oncology, Pain Management, Cardiovascular Diseases, Infectious Diseases, CNS Diseases, and Others), by Mode of Delivery (IV Set, Infusion Pump, Intravenous Injection, Intramuscular Injection, and Subcutaneous Injection), by End User (Hospitals, Ambulatory Clinics, Outpatient Facility, Infusion Therapy Center, Home Care, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Mode of Delivery (IV Set, Infusion Pump, Intravenous Injection, Intramuscular Injection, and Subcutaneous Injection), by End User (Hospitals, Ambulatory Clinics, Outpatient Facility, Infusion Therapy Center, Home Care, and Others), and by Region (North America, Latin ... Read More
-
Companion Animal Pharmaceutical Market Analysis and Forecast to 2031: By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Others), Animal Type (Dogs, Cats, Horses, Others), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies), and Region
... and Region The global companion animal pharmaceuticals market was valued at USD 12.9 billion in 2021 and it is anticipated to grow at a CAGR of 7.6% during the forecast period to reach up to ... Read More
-
2022 Global Forecast for Anti-Migraine Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Morphine Market: Segmented: by application (Pain Management, Cancer Pain, Neuropathic Pain, Osteoarthritis Pain, Other Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant); by Routine (Oral, Injectables); , And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
... Share & Trends For 2019–2020 And Forecasts To 2031 Morphine Market to surpass USD 57 billion by 2031 from USD 28 billion in 2021 at a CAGR of 7.3% in the coming years, i.e., 2021-31. ... Read More
-
Global Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Regional Outlook and Forecast, 2022 – 2028
... Analgesics Market size is expected to reach $42.6 billion by 2028, rising at a market growth of 6.6% CAGR during the forecast period. Analgesics, or painkillers, are drugs that are used to cure and relieve ... Read More
-
Global Pregabalin Market Size study, By Dosage Forms (Oral Capsule, Oral Solution, Oral Tablet, Extended Release), By Application (Epilepsy, Neuropathic Pain, Anxiety Disorder, Others), By Drug Class (Fibromyalgia Agents, Anticonvulsants, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028
... Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028 Global Pregabalin Market is valued approximately USD XX million in 2021 and is anticipated to grow with a ... Read More
-
North America Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 – 2028
... North America Analgesics Market would witness market growth of 6.1% CAGR during the forecast period (2022-2028). Migraine is a condition that is more than just a headache. Nausea, dizziness, and eye issues are common side ... Read More
-
Europe Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 - 2028
... Analgesics Market would witness market growth of 6.2% CAGR during the forecast period (2022-2028). The most often used OTC analgesic is paracetamol. It has analgesic properties similar to aspirin and ibuprofen. There are no anti-inflammatory ... Read More
-
Vagus Nerve Stimulators Market, by Product Type (Implantable Devices and External Devices), by Application (Epilepsy, Depression & Anxiety, Cluster Headache & Migraine, and Others (Crohn's disease, Dyskinesia, among others)), by End User (Hospitals, Specialty Clinics, and Others (Research Institutions, Ambulatory Surgical Centers, among others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Others (Research Institutions, Ambulatory Surgical Centers, among others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Vagus nerve ... Read More
-
Global Chronic Ocular Surface Pain Market Size study, By Drug Class (Antibiotics, Nonsteroidal Anti-Inflammatory (NSAID), Corticosteroids, Others), By Application (Sinusitis, Migraines, Glaucoma, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), and Regional Forecasts 2022-2028
... Chronic Ocular Surface Pain Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Chronic Ocular ... Read More
-
Anti-Neprilysin Market, by Drug Type (Sacubitril, TD-0714, STR-324, PL-265, LHW-090, and Others), by Indication (Acute Heart Failure, Cancer Pain, Hypertension, Alzheimer’s Disease, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharma
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Anti-neprilysin drugs are majorly used for acute heart failure, cancer pain, hypertension, ... Read More
-
Pain Management Devices And Therapies Global Market Report 2022 Including: 1) By Type: Electrical Stimulators; Ablation Devices; Neurostimulators; Analgesic Pumps 2) By Application: Neuropathic Pain; Cancer Pain; Facial & Migraine Pain; Musculoskeletal Pain; Trauma 3) By Electrical Stimulation Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Devices; Neuromuscular Electrical Stimulation (NMES/EMS) Devices; Combination Devices; Electrotherapy Devices; TNS 4) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices 5) By Analgesic Infusion Pumps: Intrathecal Infusion Pumps; External Infusion Pumps 6) By Neurostimulation Devices: Spinal Cord Stimulation (SCS) Devices; Deep Brain Stimulation Devices; Vagus Nerve Stimulation Devices; Sacral Nerve Stimulation Devices Covering: Abbott Laboratories; AstraZeneca; Pfizer; Boston Scientific Corporation; GlaxoSmithKline plc.; Teva Pharmaceutical Industries ltd.
... to assess the global pain management devices and therapies market. The report focuses on the pain management devices and therapies market which is experiencing strong growth. The report gives a guide to the pain management ... Read More
-
Intravenous Infusion Pumps Global Market Report 2022 Including: 1) By Product: Volumetric; Syringe; Enteral; Ambulatory; IV Disposables; Other Products 2) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Treatment Centers; Specialty Clinics; Other End Users 3) By Application: Chemotherapy; Diabetes; Gastroenterology; Analgesia/Pain Management; Pediatrics/Neonatology; Hematology; Other Applications Covering: B. Braun Melsungen AG; Baxter International; Medtronic; Fresenius Kabi; Smiths Medical Inc.; Becton Dickinson and Company
... global intravenous infusion pump market. This report focuses on intravenous infusion pump market which is experiencing strong growth. The report gives a guide to the intravenous infusion pump market which will be shaping and changing ... Read More
-
Digital Therapeutics Global Market Report 2022 Including: 1) By Product: Software; Devices 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C) 3) By Application: Preventive Applications; Treatment Or Care-Related Applications Covering: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Livongo Health; Propeller Health; Pear Therapeutics; Canary Health Inc.
... therapeutics market. This report focuses on digital therapeutics market which is experiencing strong growth. The report gives a guide to the digital therapeutics market which will be shaping and changing our lives over the next ... Read More
-
Liposomal Drug Delivery Devices Global Market Report 2022 Including: 1) By Type: Liposomal Doxorubicin; Liposomal Paclitaxel; Liposomal Amphotericin B; Other Types 2) By Application: Fungal Diseases; Cancer Therapy; Pain Management; Viral Vaccines; Photodynamic Therapy 3) By End User: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Other End Users Covering: Fudan-Zhangjiang; Pacira; Johnson and Johnson; Gilead Sciences; Novartis; Luye Pharma; CSPC; Ipsen (Onivyde); Teva Pharmaceutical
... assess the global liposomal drug delivery devices market. This report focuses on liposomal drug delivery devices market which is experiencing strong growth. The report gives a guide to the liposomal drug delivery devices market which ... Read More
-
U.S. Compounding Pharmacies Market, By Medication (Oral Medication(Capsules, Tablets, Mixtures, Lollipops, Lozenges),Topical Medication(Gels, Ointments, Cream, Lotions), Mouthwashes, Suppositories), By Therapeutic Area (Pain Management, Hormone Replacemen
... Medication for Children, Medication for Geriatric) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Compounding pharmacies consist of creation/compounding of pharmaceutical products tailored to fit the needs of the patient. Compounding pharmacies is ... Read More
-
Vagus Nerve Stimulators Market by Product Type (Implantable Devices, and External Devices), by Application (Epilepsy, Depression, Cluster Headache & Migraine, and Others), by Distribution Channel (Hospital, Specialty Pharmacy, and Others), by Distribution
... Pharmacy, and Online Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Vagus nerve stimulation (VNS) refers to a ... Read More
-
Neurotech Devices Market Size By Product Type (Neurostimulation {Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS)}, Neuroprostheses, Neurosensing, Neurorehabilitation Devices), By Conditions (Pain Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson's Disease, Depression, Sleep Disorders, Essential Tremor), By End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson's Disease, Depression, Sleep Disorders, Essential Tremor), By End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, ... Read More
-
2022 Global: Veterinary Pain Management - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More